Patent details

EP3908276 Title: METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

Basic Information

Publication number:
EP3908276
PCT Application Number:
US2020012783
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207036336
PCT Publication Number:
WO2020146529
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR
French Title of Invention:
MÉTHODES POUR LE TRAITEMENT DE CONDITIONS LIÉES AU RÉCEPTEUR S1P1
German Title of Invention:
METHODEN ZUR BEHANDLUNG VON S1P1 REZEPTOR BEDINGTEN KRANKHEITEN
SPC Number:

Dates

Filing date:
08/01/2020
Grant date:
11/06/2025
EP Publication Date:
17/11/2021
PCT Publication Date:
16/07/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/06/2025
EP B1 Publication Date:
11/06/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/01/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/06/2025
 
 

Name:
Arena Pharmaceuticals, Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Inventor

Name:
NAIK, Snehal
Address:
United States (US)

Priority

Priority Number:
201962789937 P
Priority Date:
08/01/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/404; A61P 37/00;

Publication

European Patent Bulletin

Issue number:
202524
Publication date:
11/06/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages